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Summary.-Previous studies have shown that in certain tissues, including colonic
carcinomas, cell proliferation may be promoted by serotonin, and indirect evidence
suggests that the effects of this amine on colonic tumours involves a cellular-uptake
mechanism. In the present study, two specific inhibitors of serotonin uptake,
Citalopram and Fluoxetine, are examined for their effects on cell proliferation and
tumour growth. Each of the agents was found to suppress cell division in dimethyl-
hydrazine-induced colonic tumours in rats, and to retard the growth of2 out of3 lines
of human colonic tumours propagated as xenografts in immune-deprived mice.
SEROTONIN is an important stimulant
to cell division in many tissues, including
both the crypt epithelium of the small
intestine (Tutton, 1974) and adenocar-
cinomas induced by dimethylhydrazine
(DMH) in the large intestine of rat
(Tutton & Barkla, 1978a). Whilst the
administration of exogenous serotonin
does not accelerate the growth of human
colorectal tumours propagated as xeno-
grafts in immune-deprived mice, treatment
with serotonin-receptor antagonists does
retard the growth of such tumours
(Tutton & Steel, 1979). It has been sug-
gested that DMH-induced tumours may
have an amine-uptake mechanism (Tutton
& Barkla, 1976b) and this suggestion, in
relationship to serotonin, can now be
tested, since several compounds have been
synthesized recently that selectively block
the cellular uptake of this amine. Fluoxe-
tine (Lilly 110140, 3 (p-trifluoromethyl-
phenoxy-N-methyl-3-phenyl propylamine)
is a potent and highly specific inhibitor of
serotonin uptake in central neurones
(Fuller & Wong, 1977; Wong et al., 1974).
Fluoxetine has also been shown to inhibit
serotonin uptake by, and to promote
serotonin efflux from, the isolated small
intestine (Gershon & Jonakait, 1979).
Citalopram (Lu 10-171, 1(3-dimethyl-
amino)propyl) - 1 - (p - fluorophenyl) - 5 -
phthalancarbonitril) also specifically in-
hibits serotonin uptake by a variety of
cells (Christensen et al., 1977; Hyttel,
1977). The present paper reports the
effects of Citalopram and Fluoxetine on
the rate of cell division in both the
intestinal epithelium and in DMH-induced
colonic tumours, and also on the growth
of 3 lines of human large-bowel cancer
propagated as xenografts in immune-
deprived mice.
MATERIALS AND METHODS
Animals.-Male Sprague-Dawley rats and
both male and female CBA/wehi mice were
used. All animals were maintained at 20-24°C
with artificial light from 07: 00 to 21: 00. Rats
were fed Clark King GR2+pellets and tap
water ad libitum. Mice were fed Barastoc
irradiated feed and tap w%ater acidified to
pH 2 with HCI ad libitum.
Induction of rat colonic tumours.-Starting
at the age of 5 weeks rats were given weekly
s.c. injections of 21 mg/kg of DMH dihydro-
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chiloride (Aldrichi Chemnical Co., linc., Mil-
waukee. Wis.) for 15 wAeeks. The stock
solution for injections comprised 400 mg of
DMH dihydrochloride dissolved in 100 ml of
distilled water containing 37 mg of ethylene
diamine tetracetic acid, and was adjusted to
pH 6-5 with NaOH. Ten wA-eeks after the
last injection, rats weret used in the experi-
ments described below-.
Estimation of mitotic sates. All rats were
injected i.p. wNith vinblastine sulphate (Velbe,
Eli Lilly Co.) 4 mg/kg at? 12:00 and killed
by decapitation between 12:45 to 16:00. The
dose of vinblastine used in this studv was
higher than in previous experiments, because
the loner dose wNas found to be ineffective in
1000 of the animals used. Counts of meta-
phase and non-metaphase cells in jejunal
crypts and in colonic adenocareinomas were
made at a magnification of 1250 x, and
metaphase indices were calculated and cor-
rected for sectioning and, when relevant,
geometric artefacts, as previously described
by Tutton & Barkla (1976a). No counts were
made on the colonic crypt epithelium, because
previous studies had shown that neither
serotonin depletion, serotonin-receptor block-
ade nor injection of serotonin significantly
influenced the mitotic rate in this tissue.
Graphs of true metaphase index vs dura-
tion of vinblastine treatment wiere then
constructed for each experimental group of
tissues having mitoses blockedfor0 75-4 00 h.
'l'he regression coefficient for each of the
graphs was then calculated by the method of
least squares; this calculated value repre-
sents the rate at which cells enter metaphase
in units of mitoses/cell/h. The statistical
significance of apparent differences between
the values of the regression coefficient for
different experimental groups of tissue was
estimated by analysis ofvariance (Bliss., 1967).
Initially, cell proliferation was studied in
the jejunal crypts of 18 normal rats and in
5 DMH-induced adenocarcinomas. Cell pro-
liferation was also studied in groups of 6
normal and 6 DMH-treated rats injected i.p.
with either Citalopram (H. Lundbeck & Co..
Copenlhagen, Denmark) or Fluoxetine (Lilly
Research Laboratories, fndianapolis, Indiana.
U.S.A.) at the times indicated in the Table.
Immunodeprivation technique. Mice were
immunodeprived by a technique similar to
that previously reported by Steel et al. (1978).
Briefly, inice aged 16-20 days were thymec-
tomized under ketamine anaesthesia (Ketlar,
18
Parke-Davis, Sydney. Australia, 0415 mg/kg
i.m.). After 18-21 days the mice were injected
wvith cytosine arabinoside (Cytosar, Upjohn
Co., Michigan) at a dose of 200 mg/kg and
were then subjected 48 h later to 8-5 Gy of
whole-body irradiation from a 137Cs source
(Gamma Cell 1000, Atomic Energy ofCanada,
Ottawa, Canada). Pretreatment with cyto-
sine arabinoside obviates the need for subse-
quent reconstitution of marrow that would
otherwise be necessary.
Xenograft technique.-Tissues from human
colorectal tumours were obtained from surgic-
ally resected specimens of large intestine and
were rapidly transported to the laboratory in
ice-cold Dulbeeco Modified Eagle's Medium
(Commonwealth Serum Laboratories, Mel-
bourne, Australia). All subsequent manipula-
tions were carried out under sterile conditions
in a Biohazard Cabinet (Clemco, Sydney,
Australia). Mice were anaesthetized with
Ketamine. Small pieces of tumour (2-3 mm
in greatest diameters) were introduced
through a single 5mm midline dorsal incision
and positioned in lateral s.c. pockets, formed
by a blunt dissection, in each flank of the
mouse. The dorsal incision was then closed
with one 9mm Auto clip (Clay Adams,
Parsippany, New Jersey, U.S.A.). After 8-12
weeks, xenografts measuring 2-3 ml were
surgically removed from mice and used to
propagate the tumour line in a second genera-
tion of mice. The procedures used for trans-
plantation into the second and subsequent
generation of mice were identical to those for
the initial transplantation. In this way par-
ticular lines of human colorectal cancer were
serially propagated. The tumour lines in the
experiment were designated HXM2, HXM3A
HXM4. The histopathology of the tumours
used in the current experiments ranged from
a moderately well-differentiated adenocar-
cinoma (HXM4) to a poorly differentiated
adenocarcinoma (HXM2). The growth of 2
of these lines (HXM2 and HXM4) had pre-
viously shown to be inhibited by the sero-
tonin-receptor antagonist BW105C (Barkla
& Tutton. 1981). By contrast, the growth of
tumour line HXM3A does not appear to be
influenced by serotonin antagonists.
Treatment.-Groups of xenograft-bearing
mice received either twice-daily i.p. injec-
tions of Citalopram (20 or 40 mg/kg) or once
daily injections of Fluoxetine (10 or 20 mg/
kg). Other groups of mice bearing xenografts
of similar size and matched for weight, sex
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TABLE.-Influence of Citalopram and Fluoxetine on the mitototic rate in the jejunal
crypt epithelium and in DMH-induced colonic tumours of rat.
Time
in r
commi
esti
Dose mit
Treatment (mg/kg)
Nil (control)
Citalopram
Fluoxetine
2
20
20
1
10
10
ofinjection
elation to
encement of Mitotic rate-mean+ s.e.
mation of (mitoses/cell/h)
totic rate
(h) Jejunal crypts Colonic tumours
- O* 0035 +0002 0*025 +0006
0 0*028 + 0*004
0 0-082*+0-013 0-003*+0-006
-15 - 0.005*+0.005
-15 - 0-023 +0-008
- 15 0.057*+ 0.005 0.003*+ 0.001
0 0 037 +0 015
* Differs significantly (P< 0 05) from corresponding control value.
and age, received twice-daily i.p. injections
of saline as controls. Each experimental and
control group of mice contained 10-13 xeno-
grafts. Three further groups of 6 immuno-
deprived mice, not bearing xenografts, were
weighed daily. One of these groups was
injected with saline, one with Citalopram
(20 mg/kg) and one with Fluoxetine (10 mg/
kg).
Tumour measurement.-Starting on the
24th day after implantation, tumours were
measured every 1-2 days for up to 30 days.
The greatest and least superficial diameters
of xenografts were measured using vernier
calipers and the volume of xenografts was
calculated as (mean diameter)3 x fl/6. The
volume of each tumour on each day of
assessment (Vt) was divided by the volume
ofthe same tumour at the start ofassessment
(Vo) to obtain the relative tumour volume
(Vt/Vo), the mean for each group of experi-
mental and control mice plotted as a function
of time. Vt/Vo was calculated because inter-
xenograft variations in this parameter arise
only during the period of treatment. The
statistical significance of apparent differences
between the relative volumes of various
groups of xenografts at particular times after
the start of treatment was assessed by the
Mann-Whitney nonparametric testforranked
observations (Sokal & Rohlf, 1969).
RESULTS
All animals well tolerated the treat-
ment with Citalopram and Fluoxetine.
The two drugs had no significant effect on
the body weight ofimmune-deprived mice
during the trial period of 14 days. Mitotic
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FIG. 1.-Graph of relative tumour volume Vs
days of treatment for tumour line HXM2.
, control; ---, Citalopram (20 mg/kg);
*, Fluoxetine (10 mg/kg).
rates for jejunal crypt cells and colonic
carcinoma cells in rat are shown in the
Table.
Growth curves for tumour line HXM2
are shown in Figs 1 and 2. Minor differ-
ences between the control lines in the two
figures exist because they are derived
from tumours of different generations;
each group of drug-treated xenografts is
compared to controls of the same genera-
tion. In each case, controls were only
measured for sufficient time to establish
that the particular group of transplants
was growing at about the same rate as in
previous generations of the same line, and
until there was a significant difference
between control and treated groups. The
two doses of Fluoxetine appear to have
had similar effects, but the higher dose of
Citalopram was significantly moreeffective
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I'l. 2. Graph of relative tumour volume vs days of treatment for tumour line HXI2. --, control;
--- Citalopram (40 mg/kg); 0, Fluoxetine (20 mg/kg).
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FoG. 3. Graph of relative tumour volume vs
(lays of treatment for tumour line HXM13A.
, control; ---, Citalopram (20 mg/kg);
*, Fluoxetine (20 mg/kg).
(P < 0.05). However, since these experi-
ments were performed on xenografts of
different generations within the same
tumour line, precise comparison is not
possible. Growth of tumour HXM3 is
shown in Fig. 3. Note that neither Citalo-
pram nor Fluoxetine had any statistically
significant effect on this line. The growth
of tumour line HXM4 is shown in Fig. 4,
both Citalopram and Fluoxetine inhibit-
ing the tumour to a similar extent on
xenografts of this line.
DISCUSSION
The preceding results clearly indicate
that the growth of some, but not all,
colonic tuimours is retarded by the sero-
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FIG. 4.- Graph of relative tumour volume vs
duration of treatment for tumour line
HXM4. --, control; ---, Citalopram
(20 mg/kg); *, Fluoxetine (10 mg/kg).
tonin-uptake-inhibiting drugs Citalopram
andFluoxetine. Theconspicuous variations
in response between different tumour lines
suggest that the inhibition is a property of
the human tumour rather than its murine
host, a suggestion that is also supported
by the observation that neither agent
significantly affected the weight of similar
mice not bearing transplanted tumours.
The contrasting responses in mitotic rate
studies in rat jejunal crypts and rat
colonic tumours also support the notion
that these agents specifically suppress the
proliferation of some tumour cells, with-
e-
f-
>-
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out having any general, antimetabolic
effect. The inhibitory responses of tumour
lines HXM2 and HXM4 were both more
profound and more prolonged than the
responses previously seen when these
tumours were treated with amine-receptor
anatagonists (Barkla & Tutton, 1981).
Both Citalopram (Overo, 1978) and Fluo-
xetine (Masala et al., 1979) have been
administered to normal human volunteers
without apparent ill-effect, though 1/9
depressed patients treated with Fluoxe-
tine did develop extrapyramidal side
effects (Melzer et al., 1979). Hence, if
sensitivity to serotonin-uptake inhibitors
proves to be a frequent property of
colonic or other human tumours, such
drugs surely deserve a Phase II trial as
antineoplastic agents.
The response of colonic carcinomas to
serotonin-uptake inhibitors lends direct
support to the concept that colonic
tumour cells, unlike jejunal or colonic
crypt cells, have a serotonin-uptake
mechanism (Tutton & Barkla, 1976b).
Two pieces of less direct evidence
have previously been reported in support
ofthis hypothesis. First, it has been shown
that inhibition of monoamine oxidase, a
group of enzymes that are responsible
only for the degradation of intracellular
amines (Neff & Yang, 1974) promotes cell
proliferation in colonic tumours but not
in the jejunal or colonic crypts (Tutton &
Barkla, 1976b). Secondly, the administra-
tion of toxic congeners of serotonin (5,6-
and 5,7-dihydroxytryptamine) rapidly
produces ultrastructurally observable,
cytoplasmic damage in colonic tumour
cells, but not in crypt epithelia (Tutton &
& Barkla, 1977, 1978b). The failure of
either Citalopram or Fluoxetine to inhibit
jejunal-crypt cell division supports the
notion that, in these cells, proliferation is
stimulated by serotonin acting on a
receptor that is located on the plasma
membrane and hence does not require an
uptake mechanism. In fact, each of these
agents actually increases the mitotic
activity in jejunal crypts, possibly by
interfering with the re-uptake ofserotonin
into the nearby enterochromaffin cells or
serotoninergic nerves from which it was
presumably released earlier. Thus there is
evidence that in normal intestinal epithel-
ial cells proliferation is stimulated by
chemical messengers acting on surface-
membrane receptors, the messenger then
being cleared from the region so that the
signal to divide is soon terminated. By
contrast, in tumours, proliferation appears
to be promoted by chemical messengers
that are taken into the cytoplasm of the
malignant cell, where the messenger may
not be subject to the normal clearance
mechanisms, and hence the signal may
persist, leading to inappropriate cell
division and the production of daughter
cells each with its own cytoplasmic supply
of stimulating messenger substance.
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